(Q34941384)

English

Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial (English)

1 reference

Europe PubMed Central

5 August 2017

Human T-lymphotropic virus 1

0 references

1 reference

based on heuristic

inferred from title

spastic paraparesis

1 reference

based on heuristic

inferred from title

14

object named as

Hideki Sakai

1 reference

Europe PubMed Central

5 August 2017

author name string

Tatsufumi Nakamura

1

1 reference

Europe PubMed Central

5 August 2017

Tomohiro Matsuo

2

1 reference

Europe PubMed Central

5 August 2017

Taku Fukuda

3

1 reference

Europe PubMed Central

5 August 2017

Shinji Yamato

4

1 reference

Europe PubMed Central

5 August 2017

Kentaro Yamaguchi

5

1 reference

Europe PubMed Central

5 August 2017

Ikuo Kinoshita

6

1 reference

Europe PubMed Central

5 August 2017

Toshio Matsuzaki

7

1 reference

Europe PubMed Central

5 August 2017

Yoshihiro Nishiura

8

1 reference

Europe PubMed Central

5 August 2017

Kunihiko Nagasato

9

1 reference

Europe PubMed Central

5 August 2017

Tomoko Narita-Masuda

10

1 reference

Europe PubMed Central

5 August 2017

Hideki Nakamura

11

1 reference

Europe PubMed Central

5 August 2017

Katsuya Satoh

12

1 reference

Europe PubMed Central

5 August 2017

Hitoshi Sasaki

13

1 reference

Europe PubMed Central

5 August 2017

Atsushi Kawakami

15

1 reference

Europe PubMed Central

5 August 2017

language of work or name

0 references

publication date

15 August 2013

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

11

1 reference

Europe PubMed Central

5 August 2017

182

1 reference

Europe PubMed Central

5 August 2017

https://scigraph.springernature.com/pub.10.1186/1741-7015-11-182

0 references

Safety of long-term treatment of HAM/TSP patients with valproic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826868

8 July 2018

Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826868

8 July 2018

HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826868

8 July 2018

Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826868

8 July 2018

Urinary and sexual manifestations of patients infected by HTLV-I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826868

8 July 2018

Urinary symptoms associated with human T-cell lymphotropic virus type I infection: evidence of urinary manifestations in large group of HTLV-I carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826868

8 July 2018

Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826868

8 July 2018

Development and validation of a quality-of-life measure for men with nocturia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826868

8 July 2018

Multiple viral strategies of HTLV-1 for dysregulation of cell growth control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826868

8 July 2018

Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826868

8 July 2018

An HTLV-I vaccine: why, how, for whom?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826868

8 July 2018

Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826868

8 July 2018

HTLV-I associated myelopathy, a new clinical entity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826868

8 July 2018

Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826868

8 July 2018

Impact of nocturia on symptom-specific quality of life among community-dwelling adults aged 40 years and older.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-11-182

21 January 2018

Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-11-182

21 January 2018

Interrater reliability of a modified Ashworth scale of muscle spasticity

1 reference

https://pubmed.ncbi.nlm.nih.gov/23945290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1741-7015-11-182

1 reference

Europe PubMed Central

5 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34941384&oldid=1858624083"